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 Blood glucose homeostasis is a critical component in the physiological health of 
vertebrates. Regulation of blood glucose levels is the responsibility of the endocrine 
pancreas, which excretes hormones to the bloodstream in response to changes in glucose 
concentrations. The hormones excreted from the pancreas include insulin, which is 
secreted form the β cells of the pancreas and signals uptake of excess glucose by the 
peripheral tissues, and glucagon, which is secreted from the α cells and signals release of 
glucose to the bloodstream through gluconeogenesis in the liver. The Krüppel-like zinc 
finger protein Gli-Similar 3 (Glis3) is a transcription factor that has been shown to play a 
critical role in the development of β cells and transcription of the insulin gene. 
 Defects in the secretion and production of insulin are associated with the 
development metabolic diseases such as diabetes mellitus. Using genome wide 
association studies, GLIS3 has been identified as a risk locus for the development of both 
type 1 and type 2 diabetes mellitus and neonatal diabetes and hypothyroidism (NDH). 
Mice with ubiquitous knockouts of Glis3 exhibit phenotypes similar to that of humans, 
but conditional knockouts specific to the pancreas have produced mice with less severe 
phenotypes, leaving the role of Glis3 largely enigmatic.    
 The zebrafish (Danio rerio) has emerged as a powerful organism in studying 
pancreatic development due to its rapid development, short generation time, and 
transparent, externally developing embryos. The zebrafish pancreas is both 
morphologically and functionally comparable to that of humans, and the developmental 
programs that are responsible for pancreatic development appear to be highly conserved 
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between the two. Zebrafish also have the unique ability to regenerate their β cells after 
complete ablation without the need for insulin treatment. These factors have made 
zebrafish a powerful model for the study of pancreatic development and diabetes.  
 We found that expression of glis3 mRNA begins after 14.5 hours post fertilization 
(hpf) in zebrafish. Zebrafish pancreas formation begins at approximately 24hpf, but 
whole mount in situ hybridization data shows that glis3 expression is restricted to the 
zebrafish brain until approximately 48hpf, when expression can be visualized in the 
pancreas. During this time frame glis3 expression levels increase, which coincide with 
the visualization of glis3 in the zebrafish pancreata. 
Finally, we found that reduction of glis3 through a knockout mutation led to 
increased production of insulin and glucagon mRNA. Additionally, glis3 heterozygous 
mutants exhibited a heightened ability to control blood glucose levels, with less 
variability of blood glucose levels between individuals under fasting, postprandial, and 
high fat diet conditions when compared to wildtype fish. After four months exposure to a 
high fat, high glucose diet, wildtype zebrafish expressed heightened levels of resting 
blood glucose, while heterozygous mutants showed no increase in blood glucose levels 
when compared to a normal diet.  
Collectively, the results of this project provide novel information regarding the 
regulation of insulin in glis3 mutant zebrafish. A decrease in glis3 expression levels may 
increase the propensity for an organism to begin the compensatory mechanism for β cell 
mass expansion, giving insight into possible models for clinical therapies for the 
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 The pancreas is a complex glandular organ located in the gut cavity that has 
multiple functions in vertebrate physiology. The pancreas is comprised of three distinct 
cell populations, including the acinar or exocrine cells, the pancreatic ductal cells, and the 
endocrine cells. These distinct cell populations give rise to the multiple functions of the 
pancreas. The acinar cells are responsible for the excretion of enzymes into the lumen of 
the small intestine, where they play a major role in the digestion of nutrients (Williams 
2010). The ductal cells form the pancreatic duct, or duct of Wirsung, and connect the 
pancreas to the common bile duct and arise from the same bipotent trunk progenitor cells 
as the endocrine cells (Alpert et al. 1988, Solar et al. 2009). The endocrine cells of the 
pancreas are responsible for the excretion of hormones into the bloodstream, which play a 
role in maintaining blood glucose homeostasis. The endocrine cells provide 
approximately only 4% of the cell population of the pancreas in mice but are composed 
of a variety of cell types including α cells, β cells, Ɛ cells, δ cells, and pancreatic 
polypeptide (PP) cells (Pelletier 1977, Andralojc et al. 2009). Each endocrine cell type is 
primarily responsible for the excretion of its own hormone: α cells secrete glucagon, β 
cells secrete insulin, Ɛ cells secrete ghrelin, δ cells secrete somatostatin, and PP cells 
secrete pancreatic polypeptide. The endocrine cells of the pancreas are arranged into the 
islets of Langerhans, spherical clusters that are embedded into the exocrine tissues of the 
pancreas (Slack 1995). The primary structure of the islet consists of a majority of 
centrally located β cells with a periphery of α cells, indicating the importance of glucagon 
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and insulin in islet function (Fig. 1). These islets are closely associated with neurons in 




Figure 1. The structure of the primary islets of the 
pancreas. The central mass of the islet consists 
primarily of insulin-producing β cells (80% of islet 
mass) with interspersed δ cells (5% of islet mass). 
The periphery of the primary islet consists of 
glucagon producing α cells (20% of islet mass). 
Axons from nearby neurons surround islets to signal 




Organogenesis of the pancreas is a complex series of steps mediated by a number 
of transcription factors. Pancreatic endocrine and exocrine cells originate from a 
population of progenitor cells that arise during the differentiation of the gut endoderm. 
During the anterior to posterior patterning of the endoderm several transcriptional cues 
cause the posteriorization of the endoderm, including fibroblast growth factor (FGF) 4 
and bone morphogenic protein (BMP) which specify foregut fate. (Deutsch et al. 2001, 
Rossi et al. 2001, Gu et al. 2002). Retinoic acid (RA) and the Wnt/β-catenin pathway are 
also required in order to signal the posterior region of the gut endoderm. (McLin et al. 
2007, Bayha et al. 2009). This anterior-posterior patterning of the gut endoderm gives 
rise to two separate epithelial buds on opposing sides of the foregut endoderm; one 
dorsally and one ventrally. These buds elongate alongside the prospective duodenum and 
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stomach and fuse together into a single organ as the gut endoderm rotates (Pictet et al. 
1972).  
 Due to the formation of the pancreas as two convergent buds, the dorsal-ventral 
patterning that gives rise to these buds is extremely important. The presence of RA is 
used to signal in part for the dorsal bud formation, but evidence shows that close 
proximity to the endothelial cells of the fusing aorta is responsible for dorsal patterning 
(Lammert et al. 2001). Before the fusion of the dorsal aorta the presumptive dorsal bud of 
the pancreas is proximal to the notochord while it secretes activin-β and FGF 2, which 
suppress Sonic hedgehog (Shh) and lead to early dorsal patterning (Hebrok et al. 1998). 
Proximity of the gut endoderm to the vitelline veins and lateral plate mesoderm 
(LPM) before fusion of the buds begins ventral patterning (Spooner et al. 1970, Lammert 
et al. 2001). Though less is known about the included pathways, signaling for the ventral 
pancreatic bud appears to be closely related to that of the dorsal bud. Dependence on 
external signals including activin-β, BMP, and RA seems to remain the same, though 
signals from the cardiac mesoderm which signal for dorsal development must be blocked 
(Lammert et al. 2001, Rossi et al. 2001). Expression of transformation growth factor 
(TGF) β has been shown to play an important role in blocking these dorsal patterning 
signals and leads to formation of the ventral bud (Wandozioch and Zaret 2009). Absence 
of FGFs and cardiogenic mesenchyme during development of the dorsal bud will lead to 
the formation of a second ventral bud, indicating that this may be the “default,” and 




After the signal induction from the notochord and LPM rapid cellular 
proliferation will give rise to the forming dorsal and ventral buds, respectively. Pancreatic 
endocrine cells arise from the dorsal bud, which begin to form the primary islets of α and 
β cells. The ventral bud is responsible for formation of the acinar and ductal cells. As 
development continues the gut endoderm rotates and brings these two buds together 
where they begin to fuse (Golosow and Grobstein 1962). After fusion, the ventral bud of 
the pancreas will begin rapid proliferation of cells as branches begin to form. These 
branches will form the ducts used to transport digestive enzymes in the gut. The leading 
cells in these expanding branches excrete pancreatic transcription factor 1 (Ptf1a) and 
will give rise to the acinar cells after the enzymatic ducts form (Zeechin et al. 2003).  
Bipotent trunk progenitors follow the leading Ptf1a expressing tip cells, which are 
capable of forming both ductal and endocrine cells during the secondary transition, a 
developmental stage where pancreatic progenitor cells are rapidly and terminally 
differentiated into their final cell fates (Wang et al. 2005, Zhou et al. 2007). 
 
Figure 2. Formation of the pancreas from convergent buds in rodents. Signals from the 
notochord induce the dorsal bud, which gives rise to the α and β cells. Signals from the 
lateral plate mesoderm cause induction of the ventral bud, which gives rise to the acinar 
and ductal cells. Twisting of the gut endoderm causes the fusion of the dorsal and ventral 
bud. Rapid proliferation and branching of pancreatic progenitor cells form the pancreatic 




Blood Glucose Homeostasis 
 In the mature organism, production and secretion of hormones from the α and β 
cells of the primary islets is highly regulated in order to maintain normal blood glucose 
levels. This rapid response system is imperative in maintaining a healthy physiological 
state. Insulin is expressed in response to high glucose levels when ATP generated during 
oxidative respiration depolarizes the plasma membrane. Ca++ ion channels open when the 
plasma membrane is depolarized, leading to the secretion of insulin (Braun et al. 2008). 
This secreted insulin then signals peripheral tissues to absorb glucose to use as energy or 
adipose tissue to convert glucose into fat for sorage, leading to decreased blood glucose 
levels. When blood sugar levels decrease insulin is down regulated, and glucagon is 
secreted from the α cells of the primary islets into the bloodstream. This glucagon is 
absorbed by the liver stimulating gluconeogenesis. Glucose created during this process is 





Figure 3. Schematic of pancreatic blood 
glucose homeostasis. At times of high blood 
glucose, insulin is released from β cells of the 
pancreas. Insulin signals periphery and adipose 
tissues to absorb glucose for energy and 
conversion into fat, decreasing blood glucose 
levels. At times of low blood glucose, α cells of 
the pancreas secrete glucagon, signaling for the 
liver to begin gluconeogenesis. This process 
forms glucose from fat, which is released to 





Following a marked increase in blood glucose levels, ubiquitous and β cell 
specific activators bind to the 340 base pair (bp) promotor region located upstream of the 
insulin transcription start site (Ohneda et al. 2000, Melloul et al. 2002). The transcription 
factors pancreatic and duodenal homeobox-1 (Pdx 1), V-maf musculoaponeurotic 
fibrosarcoma oncogene homologue A (MafA) and neurogenic differentiation 1 
(NeuroD1) are among the transcription factors responsible for the expression of insulin in 
response to glucose levels in β cells (Armata et al. 2007, Kaneto et al. 2007, Kataoka 
2007). As insulin is transcribed, it is stored in secretory vesicles in the cytoplasm to 
replenish insulin levels after secretion. In times of low blood glucose, the transcription 
factors responsible for the expression of insulin are down regulated through multiple 
mechanisms. Pdx 1 is controlled through a phosphorylation dependent manner which 
prevents its interaction with co-activators during times of low blood glucose (Mosley and 
Ozcan 2004). NeuroD1 localization is affected by glucose levels, and at low 
concentrations is located cystolicly, preventing its interaction with the insulin promoter 
region (Marcus et al. 1998). MafA is the insulin transcription factor most tightly 
controlled by glucose levels, and is only transcribed when cellular glucose levels rise 
above 10-25 mM concentrations (Sharma and Stein 1994).  
 Diabetes mellitus is characterized by β cell dysfunction and the inability to 
regulate blood glucose. Neonatal diabetes mellitus (NDM) and mature-onset diabetes of 
the young (MODY) are both monogenic forms of diabetes that affect children (Hattersley 
et al. 2009). In these forms of diabetes, a single gene mutation reduces the body’s ability 
to express insulin. Type 1 diabetes mellitus (T1DM) is caused the inability of the 
pancreas to express insulin, due to an autoimmune-mediated destruction of β cells 
7 
 
(Goodison et al. 1992). In type 2 diabetes mellitus (T2DM), tissues peripheral to the 
pancreas become resistant to insulin, decreasing the efficiency of the body to regulate 
blood glucose levels (Taniguchi et al. 2006). Along with this, it has been shown that 
insulin resistance can be compounded by deteriorating function of β cells and decreased 
islet mass (Talchai et al. 2009). The molecular mechanisms underlying the development 
T1DM and T2DM are currently unclear. Both T1DM and T2DM have been associated 
with the development of multiple comorbidities, including heart disease, neuropathy, 
strokes, and kidney failure. The cost of treating the chronic symptoms of diabetes have 
steadily risen over the years, reaching as high as 245 billion dollars in the US alone in 
2012 (Yang et al. 2013a).  
Beta Cell Mass Expansion, Neogenesis 
 Understanding β cell mass regulation is a critical issue in determine the cause of 
T2DM. Formation of β cells in the primary islets of the dorsal bud from endocrine 
progenitor cells marks the beginning of insulin transcription and of blood glucose 
regulation in developing embryos (Rossi et al. 2001, Andralojc et al. 2009). As described 
above, this initial β cell population arises from the presumptive dorsal bud of the 
pancreas due to signals from the notochord and endothelial cells of the dorsal aorta. The 
secretion of FGF from the notochord drives the rapid proliferation of progenitor cells, 
giving rise to the presumptive islets by signaling for α and β cell fates (Elghazi et al. 
2002). During the late gestational period of development, the population of β cells in the 
pancreas nearly doubles daily. This neogenesis from undifferentiated progenitor cells is 
assisted by the mitotic activity of the existing β cells, though only about 10% of the 
already existing β cells are in the mitotic state at any one time (Swenne 1982, Hellerstrom 
8 
 
and Swenne 1991). Neogenesis is the most rapid increase in β cell mass, and this time of 
fetal growth seems to be critical for determining the number of β cells in the adult 
pancreas. Despite the fact that β cell mass continues to expand after birth, embryos with 
severely decreased β cell mass during the late gestational period never catch up to their 
healthy counterparts and are more likely to develop glucose intolerance and diabetes 
mellitus (Simmons et al. 2001).  
In mice, β cells mass expands through neogenesis from ductal cells surrounding 
the islet cells for approximately one week. After this time, the precursors that are 
responsible for neogenesis of β cells disappear (Bouwens et al. 1994, Solar et al. 2009). 
The generation of new β cells then becomes possible only through the mitotic 
proliferation of existing β cells, which occurs at a highly decreased rate when compared 
to late fetal growth (McEvoy and Madison 1980, Kaung 1994). In models where β cell 
proliferation was restricted during the late gestational period through genetic 
manipulation or through dietary restriction in the mother, it has been shown that mitotic 
proliferation of the existing β cell population is unable to compensate for the loss of the 
critical mass expansion from progenitor cells (Garofano et al. 1998, Simmons et al. 
2001). 
Beta Cell Mass Expansion, Compensation  
 Throughout adult life, β cell mass increases in order to compensate for the 
increased body mass of the individual (Montanya et al. 2000). This compensation is 
carried out through the same proliferation mechanism as postnatal growth, and because of 
this, the number of islets in the adult pancreas remains constant throughout the life cycle 
(Dor et al. 2004, Solar et al. 2009). Even though adult proliferation of β cells is relatively 
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slow, there is evidence of a compensation of β cell mass in response to excessive weight 
gain leading to obesity. In rodent models for obesity, there was shown to be a 
compensatory fourfold increase in β cell mass when compared to lean controls (Pick et al. 
1998). The mechanisms of this compensatory mass expansion are currently unknown in 
mammals, as there does not appear to be an increase in β cell proliferation (Montanya et 
al. 2000), but may include neogenesis, slight increases in proliferation, or hypertrophy 
(Arystarkhova et al. 2013).  
GLIS3 
Krüppel-like zinc finger proteins make up one of the largest families of 
transcription factors, which is separated into subfamilies based on the number of zinc 
fingers motifs, sequence homology between the motifs, and the presence of certain 
transactivation domains (Williams et al. 1995, Poncelet et al. 1998). The Gli-similar 1-3 
proteins (Glis 1-3) are a subfamily of the Krüppel-like zinc finger proteins similar to the 
Gli and Zic subfamilies (Kinzler et al. 1988, Lamar et al. 2001, Kim et al. 2003, 2005). 
The human gene GLIS3 is mapped to chromosome 9p24.2 and spans 495 kb, coding for a 
protein that is 90 kDa. GLIS3 contains nine exons and eight introns, sharing about 80% 
homology between the human GLIS3 and the mouse Glis3 genes (Kim et al. 2003, 2005). 
Homologs have also been identified in zebrafish (glis3, sharing 48-49% homology), as 
well as gleeful (gfl) and lame duck (lmd) in Drosophila (Duan et al. 2001, Furlong et al. 
2001, ZeRuth et al. 2011) The GLIS3 gene reportedly has several possible alternative 
transcripts, though the physiological function of any proteins generated by these 
transcripts is currently unknown (Senee et al. 2006).  
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 The human GLIS3 protein contains a series of five Cys2-His2 zinc fingers motifs 
separated by the conserved amino acid sequence of T/SGEKPY/F, a sequence that is 
shared with the closely related Zic and Gli subfamilies (Agata et al. 1999, Kim et al. 
2003). This domain spans from exons 2-4 of the gene and is used to interact with target 
DNA sequences (Kim 2003). The GLIS3 zinc fingers can bind at the Glis3 consensus 
sequence of 5’-(G/C)TGGGGGG(A/C)-3’ (Beak et al. 2008) and the closely related Gli 
protein consensus sequence, although with much lower affinity (Lamar et al. 2001, 
Nakashima et al. 2002, Kim et al. 2003). The GLIS 3 gene also contains a transactivation 
domain on the C-terminal end that is critical in the activation of target genes (Kim et al. 
2003, Beak et al. 2008) as well as an N-terminal conserved region (Fig. 4). The function 
of the N-terminal conserved region is still mostly unknown, but there is some evidence 
that it serves a role in protein-protein interaction. (Kim et al. 2003, ZeRuth et al. 2015).  
 
Figure 4. Map of the conserved regions in the Glis3 protein across homologs. Important 
regions include the N-terminal conserved region (NCR), zinc finger binding domain 
(ZFD), the C-terminal transactivation domain (TAD), and the Glis binding site (Glis BS). 







 During development, Glis3 expression is controlled both temporally and spatially. 
In mice, Glis3 RNA expression begins at E8.0 and can be seen in the pancreas, kidney, 
testes, lungs, brain, and eyes (Kim et al. 2003, Kang et al. 2009). Postnatally (E16.5-
E18.5) Glis3 expression in the pancreas is restricted to the ductal cells and islet β cells 
(Senee et al. 2006, Kang et al. 2009). In the adult mouse, Glis3 expression continues in 
the pancreas, kidney, testes, retinas, brain, and lungs (Kim et al. 2003, Beak et al. 2007). 
Using EGFP-tagged Glis proteins it has been shown that these proteins are predominately 
expressed in the nuclei of exponentially growing cells (Kim et al. 2002, 2003, Zhang et 
al. 2002, Beak et al. 2008). While Glis3 contains nuclear location signals (NLS), 
mutation of these NLS, along with detailed studies of the mutations of individual zinc 
fingers (ZF) in the Glis3 ZFD have shown that the NLS are not required for the 
localization of Glis3 to the nucleus, but that mutation of ZF4 greatly decreases the 
accumulation of Glis3 in the nucleus (Kim et al. 2003, Zhang et al. 2002, Beak et al. 
2008). Along with the nucleus, Glis3 accumulation can be measured in the primary 
cilium, much like the closely related Gli subfamily of proteins (Haycraft et al. 2005, 
Hashimoto et al. 2009). The primary cilia of cells are critical for the function of Shh- and 
Wnt- mediated signaling, and dysfunction of cilia leads to multiple ciliopathies (Oro 
2007, Rohatgi et al. 2007, Veland et al. 2009).  
Glis3-Associated Pathologies 
Because of its early expression during development and the subcellular 
localization in the nucleus and primary cilia of rapidly proliferating cells, we know that 
Glis3 plays an important role in developing and adult cells. This is supported by the fact 
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that disfunction in the expression and transcription of Glis3 in humans has been linked to 
the development of neonatal diabetes and hypothyroidism (NDH) and polycystic kidney 
disease (PKD) (Taha et al. 2003, Senee et al. 2006). NDH is characterized by 
hyperglycemia, hypoinsulemia, neonatal diabetes, and elevated thyroid stimulating 
hormone (Senee et al. 2006). NDH is also accompanied by multiple severe symptoms, 
including but not limited to cholestasis, hepatic fibrosis, congenital glaucoma, and facial 
deformities (Taha et al. 2003, Senee et al. 2006). PKD is characterized by the 
development of enlarged cysts in the kidneys, leading to kidney failure and death (Taha 
et al. 2003, Senee et al. 2006).  
Glis3 knockout mice exhibit similar phenotypes of Glis3 mutant humans, 
including NDH, PKD, and small, misshapen primary islets in the pancreas (Kang et al. 
2009, Watanabe et al. 2009). One identified target gene for Glis3 is insulin, indicating 
that Glis3 may play an important role in the development of the endocrine pancreas or in 
the differentiation of β cells (Kim et al. 2003, Senee et al. 2006, Kang et al. 2009, Yang et 
al. 2009).  This is supported by the fact that a human genome-wide association study has 
identified GLSI3 as a risk locus for the development of both T1DM and T2DM (Barrett 
et al. 2009, Boesgaard et al. 2010, Dupuis et al. 2010).  
Glis3-Mediated Gene Regulation 
 The mechanism through which Glis3 dysfunction leads to NDH and PKD are not 
fully understood, though the localization of Glis3 in the primary cilia gives indication in 
its role in the development of renal disease. For starters, NDH and PKD are both 
categorized as ciliopathies, which are caused by disruptions in the primary cilia (Saunier 
et al. 2005, Bisgrove and Yost 2006, Torres and Harris 2006). The primary cilia are 
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immotile, thread-like structures that extend from the cell into the extracellular matrix 
(Bisgrove and Yost 2006, Fliegauf et al. 2007, Berbari et al. 2009). Each cilium is 
composed of nine microtubule doublets that form an axoneme, surrounded by a 
continuation of the cellular plasma membrane (Bisgrove and Yost 2006, Berbari et al. 
2009). A process called intraflagellular transport (IFT) is used to mediate the travel of 
ciliary proteins along the length of the axoneme (Rosenbaum and Witman 2002, Fliegauf 
et al. 2007, Gerdes et al., 2009). Because of the role of IFT in the transport of ciliary 
proteins into the primary cilia, the primary cilia functions as a chemo-, photo-, and 
mechano-sensor. The specialized plasmid membrane surrounding the primary cilia also 
gives it a role in the Shh- and Wnt- dependent signaling pathways (Oro 2007, Rohatgi et 
al. 2007, Corbit et al. 2008).   
 Because of the similarities in the Glis and Gli subfamilies of the Krüppel-like zinc 
finger proteins, it is hypothesized that Glis3 interacts with the primary cilia in a similar 
mechanism to the Shh/Gli3 pathway (Attanasio et al. 2007, Kang et al. 2009). A 
hypothetical model of Glis3 activation mirroring that of Gli3, has been suggested due to 
the similarities in subcellular localization. In this hypothetical model, activation of a 
membrane bound protein in the cilia activates IFT, leading to accumulation of Glis3 in 
the primary cilia (Haycraft et al. 2005, Kim et al. 2009, Kang et al. 2010). At this point 
activation of Glis3 may be dependent on phosphorylation or proteolytic processing. 
Following this processing and translocation back into the nucleus, Glis3 proteins can then 
repress or activate the transcription of target genes (Kim et al. 2002, Kang et al. 2009, 
Kang et al. 2010). More study is needed in order to identify the molecular components 
for each step, but initial studies have indicated that the Glis3 model appears to be highly 
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similar to that of the Shh/Gli3 model (Kim et al. 2002, Zhang et al. 2002, Hoskings et al. 
2007).  
 Much like the molecular components of the proposed model for Glis3 activation, 
the mechanism by which Glis3 activates or repress transcription is not currently known. It 
has been shown that Glis3 works with multiple cofactors at the site of transcription in 
order to activate or repress target genes (ZeRuth et al. 2013). Glis3 was shown to be able 
to recruit Creb-Binding Protein (CBP/p300) (ZeRuth et al. 2013) in order to promote the 
transcription of insulin through protein-protein interactions with Pdx1, MafA, and 
NeuroD1 (Naya et al. 1997, Pashavaria et al. 1997, Qiu et al. 1998, Ohneda et al. 2000). 
Additionally, Glis3 has been shown to interact with WW domain-containing 
transcriptional regulator 1 (Wwtr1), which in turn interacts with various other 
transcriptional factors as either a coactivator or corepressor (Hong et al. 2005, Hong and 
Yaffe 2006, Kang et al. 2009). 
Zebrafish as a Model Organism 
 In recent years, the zebrafish (Danio rerio) has begun to emerge as a powerful 
model for the study of pancreatic development. Danio have several advantages over the 
more commonly used mouse models, including rapid development, short generation time, 
and an amenability to genetic techniques (Streisinger et al. 1981). A single female can 
give rise to a clutch of 200-300 transparent, externally developing eggs at a time. The 
transparency of these eggs is important for the ability to efficiently visualize the 
developmental processes. Moreover, since zebrafish are reared in water, application of 
drugs is accomplished by simply placing the drugs in the water, as with tricaine-S 
anesthesia (Matthews and Varga 2012).  
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 Importantly, the pancreatic development of the zebrafish appears to be highly 
conserved with that of humans and mice models (Pack et al. 1996, Argenton et al. 1996, 
1997). RA signaling in the anterior endoderm specifies for a pancreatic fate, and 
Wnt/beta-catenin signaling has been shown to be responsible for tissue patterning, much 
like in mammals (Stafford and Prince 2002, Goessling et al. 2008). The cellular structure 
of the zebrafish pancreas matches that of mammalian models, with exocrine and ductal 
cells forming alongside the endocrine cells in two separate buds, one ventral and one 
dorsal (Argenton et al. 1999, Biemar et al. 2001, Devos et al. 2002, Pauls et al. 2007). 
Preliminary studies have shown that a fraction replicating β cells persist throughout the 
life of the adult fish (Yee et al. 2001, Pisharath et al. 2007). This can be related to the 
replication that is responsible for β cell mass expansion through adulthood in mammals 
(Kaung 1994, Teta et al. 2005). One unique feature that sets the zebrafish apart from 
rodent models is that ability to regenerate its β cells after complete ablation (Pisharath et 
al. 2007, Xu et al. 2008, Moss et al. 2009). The ability of zebrafish to regrow β cells after 
complete ablation indicates that adult zebrafish have a maintained population of 
pancreatic progenitor cells, something that seems to be lacking in mammals, as β cell 
mass expansion appears to be achieved through β cell proliferation alone (Bouwens et al. 
1994, Solar et al. 2009). However, in zebrafish β cell mass expansion in response to 
nutrient excess stems primarily from neogenesis from postmitotic progenitor cells (Enrico 
et al. 2009). Understanding the mechanisms of β cell mass expansion in response to 
nutrient excess can be the first step to the development of clinical treatment for β cell 
dysfunction and glucose intolerance caused by obesity. By understanding the mechanism 
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through which β cell regeneration is achieved, it is possible that new clinical therapies for 
T2DM can be explored.  
 While pancreatic morphology and function appear to be highly conserved 
between mammals and zebrafish, there are key differences in pancreatic organogenesis. 
Neurogenin 3, a key transcription factor responsible for the differentiation of islet cells 
(Gu et al. 2002, Rukstalis and Habener 2009), has no known homologue in zebrafish. 
Endocrine cell differentiation in zebrafish appears to instead be under control of signaling 
from the transcription factor Soxb9 (Huang et al. 2016). In addition to this, zebrafish 
pancreata form endocrine cells in scattered bilateral rows, that migrate to form a single 
islet during late-somitogenesis (Biemar et al. 2001). Migration of endocrine cells appear 
to be under the control of glypican knypek (gpc4) as loss of this gene function causes the 
failure of the bilateral endocrine primordia to merge (Biemar et al. 2001). 
 Due to a partial duplication of its genome, zebrafish tend to have multiple 
homologues of genes that are unique in mammals, making complete knockdown studies 
difficult in some cases (Force et al. 1999, Blader et al. 2004, Zecchin et al. 2007). 
However, there is only one glis3 ortholog in the zebrafish genome on chromosome 10, 
which is responsible for encoding a 2,785 bp transcript (Howe et al. 2013, O’Hare et al. 
2016). This transcript encodes for a protein that is 787 amino acids and has 49% 
homology with the human Glis3 gene (Howe et al. 2013). This homology rises to more 
than 90% when comparing the critical zinc finger binding domains, and luciferase assays 
have been used to show that zebrafish glis3 is capable if activating the human insulin 
gene (Howe et al. 2013, ZeRuth et al. 2015).  
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 Preliminary studies of glis3 localization and function have already been 
performed in zebrafish. Using oligonucleotide riboprobes, glis3 mRNA localization was 
determined in a process called whole mount in situ hybridization. These synthetic 
riboprobes hybridize to the glis3 transcript sequence and emit a fluorescent signal due to 
the digoxigenin-11-dUTP used during riboprobe synthesis (Fig. 5A). glis3 expression has 
been measured in the brain and pancreas of developing zebrafish as early as 24hpf and 
48hpf, respectively. Using a process called morpholino knockdown, glis3 RNA 
translation was blocked using morpholino oligos. This process is becoming an advanced 
tool for silencing the translation, splicing, or ribosomal activity of target RNAs. By 
silencing glis3 translation in developing embryos, a marked decrease in the number of 





Figure 5. Preliminary analysis of localization and function of glis3. A. Whole mount in 
situ hybridization was used to determine the localization of glis3 in developing zebrafish 
embryos. Fluorescently labeled digoxigenin-11-dUTPs are used to synthesize riboprobes 
that hybridize to glis3 mRNA. glis3 expression can be seen in the zebrafish brain at 
24hpf, and in the developing pancreas as early as 48hpf. B. Morpholino oligos were used 
to silence glis3 mRNA translation. Reduction of glis3 expression due to morpholino 
knockdown was responsible for a reduction in insulin and glucagon expression in the 
developing zebrafish pancreas.  
  
Knockout studies of glis3 have been conducted in another small fish model called 
Medaka (Oryzias latipes). A transposon was found to be inserted in the fourth intron of 
glis3, resulting in a mutated zinc finger binding domain and a truncated protein. Medaka 
with glis3 nonsense mutation exhibited the expected phenotype of PKD, including renal 
cyst formation and decreased urine flow rate (Hashimoto et al. 2009). However, unlike 
humans and mammals Medaka glis3 mutants used showed none of the symptoms of a 
pancreatic phenotype, indicating a possible redundancy for glis3 in pancreatic function in 
Medaka (Hashimoto et al. 2009). By using zebrafish as a model organism to study the 
effects of glis3 mutation, it may be possible to develop models for the study of NDH, 
T1DM, and T2DM. By subjecting glis3 mutant zebrafish to a high fat, high glucose diet, 
we hope to identify the effects of glis3 mutations on the pancreatic islet mass expansion 
in response to nutrient excess. Identification of target genes in pancreatic endocrine cell 
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differentiation can eventually lead to generation of β cells from induced pluripotent stem 
cells (iPSCs) for use in β cell transplant. Identification of the mechanisms responsible for 
regeneration of β cells in zebrafish can lead to the use of regeneration as a clinical 










































Material and Methods 
Zebrafish Housing  
 The zebrafish where housed using a standard AQUANEERING aquatic housing 
system. Briefly, adult fish where housed in either 6.0 or 2.8 L tanks, containing a 
maximum of 30 or 14 fish, respectively (Vargesson 2007). These tanks are part of a five-
rack continuous flow system maintained at a pH of 7.0 and a temperature of 27o C. The 
entire rack system is on a scheduled 14-hour light cycle to optimize zebrafish health and 
breeding (Lopez-Olmeda et al. 2006). Flowing water undergoes mechano-, UV-, and bio-
filtration to remove particulates, microbial life, and ammonia. Half of the water in the 
system is replaced daily using a timed water exchange tank to supplement the filtration. 
Zebrafish are fed GEMMA Micro 300 at 5% of biomass once daily.  
Zebrafish Lines 
 The wildtype zebrafish line used is the AB line, ordered from the Zebrafish 
International Resource Center (ZIRC). The mutant line of zebrafish used is a glis3+/- 
heterozygote generated by ENU mutagenesis. Generation of mutants through ENU 
mutagenesis has been previously described (Kettleburough et al. 2013). Specifically, the 
heterozygous line is glis3+/sa17645, and was purchased from ZIRC. This line of mutant fish 
contains a C/T mutation within exon 2 of the gene coding glis3, resulting in an early stop 
codon (Fig. 6). This early stop codon leads to a truncated protein containing only 47 
amino acids that lacks the zinc finger binding domain, the transactivation domain, and the 
N-terminal conserved region of glis3. Since it lacks all the conserved regions of glis3 that 
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have been identified as crucial for glis3 function, it is expected that the protein produced 
will act as a sufficient knockout. 
Figure 6. Schematic of the glis3+/sa17645 mutant. Shaded rectangles indicate exons of the 
glis3 gene. Relative positions of the start and stop codons are indicated.  The mutated 
region in exon 2 found in glis3sa17645 zebrafish is shown in detail. The wild type glis3 
product is comprised of 787 amino acids while the glis3sa17645 nonsense mutation 
prematurely truncates the protein at Gln47.  NCR = N-terminal conserved region; ZFD = 
zinc-finger domain; TAD = transactivation domain. 
 
Zebrafish Breeding 
 In order to obtain a complete glis3 knockout model, the heterozygous glis3+/sa17645 
mutants were intercrossed. Following the development of glis3sa17645/ sa17645 males, these 
where then crossed with heterozygous glis3+/sa17645 females to increase the yield of 
glis3sa17645/ sa17645 mutants. Zebrafish breeding protocol has been previously described 
(Naiadka and Clark 2012). Briefly, 1 female and 2-3 males are placed in a 1.0 L 
AQUANEERING crossing tank with a divider overnight. At the onset of the light cycle 
the divider is removed and zebrafish are allowed to spawn and fertilize the eggs, which 
fall through the slotted bottom of the inner tank. After spawning, the eggs are removed 
and placed in E2 media until hatched (approximately 5 dpf).  
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 After hatching, larval fish are placed in a 1.8 L still water nursery tank at no more 
than 50 larval fish per tank (Vargesson 2007). Larval fish are fed concentrated ground 
paramecia until 9 dpf. Following 9 dpf, larval fish are transferred to the continuous flow 
system, and fed ZIRC Nursery Mix twice daily until 21 dpf. At 21 dpf the larval diet is 
switched to the standard GEMMA Micro food supplemented with ZIRC Nursery Mix 
once daily until 45 dpf, at which point the larval fish begin to follow the adult dietary 
protocol outlined above.  
TaqMan SNP Genotyping Assays 
 TaqMan SNP genotyping assays were used to verify the genotype of offspring 
generated by glis3+/sa17645 x glis3+/sa17645 crosses. 90-day old fish where anesthetized using 
tricaine-S and tail clippings where taken. Anesthetization by tricaine has been previously 
described (Matthews and Varga 2012). Before tail clipping, zebrafish were weighed and 
measured to determine if a reduction or loss of glis3 during development effected 
phenotypic body size. After tail clipping, zebrafish where kept in isolation for ten days to 
allow their tail to regrow, and then where sorted into tanks with siblings that shared 
genotype. DNA from tail clippings was extracted using HotSHOT DNA extraction 
(Meeker et al. 2007).  
 Site directed mutagenesis was used to create the hypothesized C/T mutation in 
wildtype zebrafish DNA in order to use as a positive control for the TaqMan SNP 
genotyping assays. Wildtype glis3 was generated by PCR amplification using the drglis3 
EcoRI IN and drglis3 BamHI OUT primers and inserted into the pCRII-TOPO plasmid. 
The glis3-pCRII-TOPO plasmid was inserted into DH5α cells grown on Amp+ LB 
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culture plates. Colonies were selected and cleaned using a plasmid miniprep kit 
(ThermoFisher) using the manufacturer’s protocol.  
 Wildtype glis3 DNA was then mutated using the glis3 sa17645 C>T F and glis3 
sa17645 C>T R primers and PFU Turbo DNA polymerase. glis3-pCRII-TOPO plasmid 
DNA was incubated in the restriction enzyme Dpn I to remove unmutated DNA. Mutated 
DNA was then transfected into XL10-Gold competent cells and grown on AMP+ LB 
culture plates. Colonies were selected and cleaned using a plasmid miniprep kit 
(ThermoFisher) using the manufacturer’s protocol. Mutated DNA was removed from the 
glis3-pCRII-TOPO plasmid using the restriction enzyme EcoRI. Mutation was verified 
by sequencing. 
Primer Name Primer Sequence (5’ to 3’) 
drglis3 EcoRI IN ATGCGAATTCAGCTCAGATATCTCCA 
drglis3 BamHI OUT GTCAGGATCCTCAGCCTTCAGTGAA 
glis3 sa17645 C>T F CCGAGCTCTTCATCAATAGGCTCCACAGATTTC 
glis3 sa17645 C>T R GAAATCTGTGGAGCCTATTGATGAAGAGCTCGG 
Table 1. List of primers used for site directed mutagenesis of glis3. 
 Wildtype zebrafish DNA, heterozygous glis3+/sa17645 DNA, and the mutated 
glis3sa17645/sa17645 DNA were used as positive controls for genotyping the glis3+/sa17645 x 
glis3+/sa17645 cross offspring. TaqMan SNP genotyping assays use two probes that differ in 
sequence only at the SNP site. Each probe contains a covalent linked 5’ reported dye and 
3’ quencher dye (Fig. 7). While the probe is intact, the quencher dye suppresses the signal 
of the reporter dye. Cleaving of the reporter and quencher dyes is accomplished by Taq 
polymerase if the probe and DNA are exactly complimentary. If the pairing is off by one 
nucleotide because of the SNP, then the probe is dislodged and the reported dye signal is 
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not received. By comparing the ratio of the signal received from the two reporter dyes, it 
is possible to determine the ratio of the genes expressed.  
 
Figure 7. Schematic of the mechanism of TaqMan SNP genotyping assays. D1 and D2 
are the reporter dyes for the separate probes. Q is the quencher dye, the orange circle is 
Taq polymerase, and the dark arrow are the forward primers. (Adapted from 
http://www.applied-maths.com/applications/taqman-based-snp-genotyping).  
 
Blood Glucose Determination 
The method for measuring blood glucose levels in zebrafish have been previously 
described (Eames et al. 2010). Briefly, fish are anesthetized in water at 0 oC, as tricaine-S  
anesthetization interferes with glucose levels (Eames et al. 2010, Matthews and Varga 
2012). Fish are then decapitated, and blood glucose is measured using the FreeStyle Lite 
Blood Glucose and Monitoring System. Blood glucose measurements were taken for 
wildtype and glis3+/sa17645 heterozygotes while fasting, post prandially, and following 
application of a high fat, high glucose diet.  
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To simulate a high fat diet (HFD) that leads to the onset of diabetes, 3 wildtype 
and 3 glis3+/sa17645 fish where submerged in 10.0 g of 99% D-glucose (Sigma-Aldrich) 
dissolved in 500 ml of system water. They were then fed 0.1 grams of powdered chicken 
egg yolk (Sigma-Aldrich) in supplement to their normal diet. This regiment was repeated 
3 times a week for 4 months.  
 After the measurement of blood glucose levels, fasting and postprandial fish 
where dissected to determine the concentration of glis3, insa, gcga, and gcgb in the 
pancreas, kidney, brain, and gonads. Fish exposed to the HFD where fixed in 4% 
paraformaldehyde (PFA) and mounted in Paraplast X-TRA for sectioning to determine if 
reduction in glis3 effected β cell mass expansion in response to nutrient excess.  
Quantitative Reverse Transcriptase Real-Time PCR Analysis 
 RNA was isolated from wildtype eggs or wildtype and glis3+/sa17645 heterozygote 
organs using TRIzol RNA Extraction (Simms et al. 1993). Equal amounts of RNA were 
used to generate cDNA using a high capacity cDNA kit (Applied Biosystems). cDNA 
was then analyzed by quantitative real time PCR using the PowerUP SYBR green master 
mix (ThermoFisher Scientific). All qRT-PCR was performed using the Applied 
Biosystems 7500 real time PCR system. Primers used during RT-PCR are listed below 
(Table 2). GapDH and eIF1A were used to normalize RNA levels across different cell 
types and ages.  
Immunohistochemistry and Microscopy 
 Zebrafish gut sections where fixed in 4% paraformaldehyde for 3 hours and 
washed in PBS. Tissue samples where then dehydrated with serial dilutions of ethanol in 




Gene Target Primer Sequence (5’ to 3’) 
glis3 F- ATGCGAATTCAGCTCAGATATCTCCA 
R- GTCAGGATCCTCAGCCTTCAGTGAA 
insa F- CTGTGTGGATCTCATCTGGT 
R- CTCTCTTCCTTATCAGCTCG 
gcga F- CGACAGCACAAGCACAGAGACAG 
R- GACGTTTGACAGAACCACCATTTC 
gcgb F- GGAAAACGGCAGCCTTATGTCTG 
R- CGTGTCGGGACTCCACTCCTCT 
gapdh F- CGTCTGGTGACCCGTGCTGCTTT 
R – AGTGGAGGCTGGGATGATGTTCT 
Table 2. List of primers used for RT-PCR. 
Hemo-De and decreasing concentrations of ethanol. After infiltration, gut tissues where 
incubated at 65o C in 50% Hemo-De/50% Paraplast X-TRA (Sigma-Aldrich) for one 
hour, and then 100% Paraplast X-TRA at 65o C overnight. Tissue samples where then 
embedded in Paraplast X-TRA and allowed to cool overnight.  
 Paraplast blocks were sectioned into 20 um samples using the Spencer 820 Rotary 
Microtome and mounted on Superfrost Plus microscope slides (Fisherbrand). Mounted 
paraplast sections were allowed to dry at RT overnight. Sections were rehydrated in serial 
dilutions of ethanol with decreasing concentrations of alcohol. After rehydration of tissue 
sections, antigen retrieval was performed on slides preceding immune histochemical 
staining began. Both enzymatic (Shi et al. 1997) and heat-mediated antigen retrieval 
(Norton et al. 1994, von Wasielewski et al. 1994) were attempted.  
 For enzymatic antigen retrieval, slides were blotted dry and individual samples 
were enclosed with a hydrophobic barrier pap pen (Aqua Hold II). 100 ul of prewarmed 
0.05% trypsin was applied to each sample, and then incubated at 37o C for 20 minutes. 
Samples where then rinsed with running water for three minutes. For heat-mediated 
antigen retrieval, slides were immersed in Sodium Citrate Buffer (10mM Sodium Citrate, 
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0.05% Tween 20, pH 6.0) heated to 100o C for 20 minutes. Samples were then rinsed 
with cold running tap water for 10 minutes.  
  Slides were rinsed in TBS plus 0.025% Triton X-100 with gentle agitation and 
blocked with 10% normal sheep serum with 1% bovine serum albumin (BSA) in TBS for 
2 hours at RT. Slides where then drained and again enclosed with the hydrophobic barrier 
pap pen and incubated over night at 4o C in 100 ul of 7 ug/ml Monoclonal Anti-Glucagon 
antibodies grown in mouse (Sigma) and 5 ug/ml Rb pAb to insulin (Abcam) primary 
antibody diluted in TBS with 1% BSA. Slides where then rinsed in TBS 0.025% Triton 
with gentle agitation. Tissues were then stained with 100 ul of 4 ug/ml anti-rabbit 
AlexaFluor 594 secondary antibody (ThermoFisher Scientific) and 4 ug/ml anti-mouse 
AlexaFluor 488 secondary antibody (ThermoFisher Scientific) for 1 hour at RT in the 
dark. Slides where then rinsed in TBS and mounted using Prolong Diamond anti-fade 
with DAPI (Life Technologies) and sealed with clear nail polish. Slides where observed 
using a Leica DMi8 fluorescence inverted microscope (Leica Microsystems) and images 
where captured using a DFC7000T cooled fluorescence camera and LAS X Expert 












glis3 Expression Begins After 14.5 hpf in Wildtype Zebrafish 
 In order to determine when glis3 RNA transcription begins in wildtype zebrafish, 
total RNA was harvested from zebrafish eggs every two hours during development, 
starting at 5 hpf when maternal RNA is degraded (Abrams and Mullins 2009). The total 
RNA was converted into cDNA and used in quantitative reverse transcriptase real-time 
PCR analysis (qRT-PCR) to determine glis3 RNA expression levels. In addition, the 
expression of insa and pdx 1 RNA levels were measured as positive controls, as it is 
known that Pdx 1 expression begins at 13 hpf (Kimmel et al. 2011) and insa expression 
begins approximately 17 hpf (Papasani et al. 2006). Expression of glis3 was shown to 
begin after 14.5 hpf (Fig. 8), as measured by a significant change (p < 0.05) in expression 
levels from 5 hpf, where the transition from maternal to zygotic RNA expression begins 
(Abrams and Mullins 2009). Glis3 expression increased significantly again at E18.5 
exhibiting a 3.5-fold increase in expression. During this experiment, the positive controls 
of pdx 1 and insa both show transcription start times where they have been previously 
recorded, from 11-14.5 hpf and 16.5-18.5 hpf, respectively.  
glis3sa17645 Zebrafish are Viable but Sex Determination May be Affected 
 The glis3+/sa17645 mutants described above were intercrossed in an attempt to 
generate a line of zebrafish with a ubiquitous knockout of glis3. The genotype of 
offspring generated by this glis3+/sa17645 x glis3+/sa17645 cross was determined using 
TaqMan SNP Genotyping assays. Comparison of the ratio of magnitude of two separate 
reporter dyes was used to determine the ratio of genes expressed in the offspring genome 
29 
 
(Fig. 9). Each reporter dye was specific to a certain SNP in the region being examined, so 
homozygotes for either allele would show high expression of one probe and no 
expression of the other. Heterozygous glis3+/sa17645 fish showed near  
 
Figure 8. Expression of mRNA levels during development of zebrafish embryos. qRT-
PCR was used along with PowerUP SYBR green to determine the beginning of RNA 
expression of multiple transcription factors. Pdx1 and insa are used as positives controls 
with expression beginning at 13 hpf and 17 hpf, respectively. glis3 expression was shown 
to differ from time points without expression (represented by *) at 16.5 hpf (p=0.017), 
indicating that glis3 RNA expression begins sometime after 14.5 hpf. All RNA levels 
where normalized against eIF1A expression levels. 
 
equivalent expression of both probes. The genotypic and gender ratio of the performed 
crosses were examined for any abnormalities that may be caused by the lack of glis3 
expression during development (Table 3). The observed genotypic ratio was compared to 
the expected 1:2:1 ratio using the Chi Squared test (χ2) and a χ2 value of 1.628 was 
determined for the offspring genotypes. With two degrees of freedom, this means that the 
observed genotypic ratio is not statistically different from the hypothetical ratio 
(p=0.443). When comparing the gender ratio, a χ2 value of 4.829 was obtained, which 
30 
 
indicates a significant difference in the expected gender ratio (p=0.028). However, until 
the line is further developed it is difficult to determine if this is a biologically significant 
difference or if difficulty in determining the sex of young adult zebrafish has skewed this 
data. Interestingly, the gender ratio is skewed more highly with reduction of glis3, while 
wildtype exhibit the expected 1:1 ratio. Unfortunately, the cause behind gender 
specification in zebrafish is complex (von Hofsten and Olsson 2005), so further research 
is needed in order to determine if the deletion of glis3 may have an effect on the gender 
ratio of zebrafish.  
 
Figure 9. Determination of offspring genotype. A glis3+/sa17645 x glis3+/sa17645 cross was 
performed and DNA samples were taken using the HotSHOT DNA isolation method. 
Samples were run in duplicate using TaqMan SNP Genotyping assays to determine 
offspring genotype. Analysis of signaling dye ratio was done automatically using built in 
TaqMan Genotyper Software. 
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Gender glis3+/+ glis3+/sa17645 glis3sa17645/sa17645 
Male 4 14 6 
Female 4 7 0 
Table 3. Examination of genotypic and gender ratios of offspring. A glis3+/sa17645 x 
glis3+/sa17645 cross was performed, resulting in 8 glis3+/+ offspring, 21 glis3+/sa17645 
offspring, and 6 glis3sa17645/sa17645 offspring. This genotypic ratio is not significantly 
different from the expected model for heritable genes (p=0.443). The gender ratio is 
skewed toward males in the mutant models, with not knockout females, but with n=6 it is 
impossible to determine if this is significant until the line is further developed.  
  
While zebrafish were anesthetized for genotyping, and before sacrificing fish to 
determine blood glucose levels, mass and body length where measured to determine if 
glis3 mutation had any effect of the development of zebrafish growth. In order to account 
for differences in the size of male and female zebrafish and differences in size due to age, 
overall growth is measured as body mass index (BMI), or mass/length in g/mm. Using 
the body size measurements of 63 fish with a mix of all three genotypes, it was found that 
the reduction or deletion of glis3 does not have any significant effect on the development 
of zebrafish in regard to overall BMI (Fig. 10). Both heterozygous (p=0.228) and 
glis3sa17645/sa17645 knockouts (p=0.068) show no significant deviation from average size of 
wildtype zebrafish. The borderline p-value of glis3sa17645/sa17645 knockouts when compared 
to wildtype zebrafish is likely due to the low sample size (n=6) of glis3 knockout BMI 
and will be further scrutinized once the line is further developed.  
Reduction of glis3 May Increase Blood Glucose Regulation Efficiency 
 Wildtype and glis3+/sa17645 zebrafish had their blood glucose monitored under 
different dietary conditions in order to determine if a reduction in glis3 expression had 
any effect on blood glucose homeostasis (Fig. 11). Zebrafish were anesthetized in ice 
water as tricaine-S anesthetization interferes with glucose levels (Eames et al. 2010, 




Figure 10. glis3 reduction does not affect zebrafish body mass index. Wildtype zebrafish 
have an average BMI of 6.80 x 10-3 ± 3.95 x10-3 g/mm (n=24). Using a two-sided t-test, 
the average BMI of the glis3+/sa17645 and glis3sa17645/sa17645 were shown to not be 
significantly different (p=0.228 and 0.068, respectively).  
 
using the FreeStyle Lite Blood Glucose and Monitoring System. Baseline glucose levels 
where taken in fasting zebrafish, and immediate glucose response was measured in 
postprandial zebrafish. After four months of exposure to the high fat/high glucose diet 
described previously, resting blood glucose was then measured in wildtype and 
heterozygous fish in order to measure their ability to regulate blood glucose in response 
to nutrient excess.  
The control diet wildtype and glis3+/sa17645 showed a statistically significant 
difference in resting blood glucose levels (p=0.033). Neither the postprandial or HFD 
dietary groups show any significant different between blood glucose levels of the 
wildtype and heterozygous fish, though in the case of the HFD fish, this is likely due to 
the high fluctuations in blood glucose levels in the WT fish (p=0.142) In the HFD case 




Figure 11. Blood glucose levels of fish with different dietary constraints. Blood glucose 
measurements were taken from fasting and postprandial control fish. Fasting 
heterozygotes exhibit lower resting blood glucose than wildtype counterparts (p=0.033). 
Fish exposed to a high fat diet (HFD) where then fasted and had resting blood glucose 
measurements take to determine if long term exposure to nutrient excess affected blood 
glucose homeostasis. There was no statistical significance in the difference in blood 
glucose levels between WT and heterozygous fish (p=0.142), though this is believed to 
be due to the high variability in in the WT fish, which were beginning to exhibit signs of 
T2DM. There was also no significant difference in the resting blood glucose levels of the 
control and HFD heterozygous fish (p=0.354). All blood glucose was measured using the 
FreeStyle Lite Blood Glucose and Monitoring System. 
 
deviation = 0.10). Wildtype fish exposed to the HFD exhibit less efficient blood glucose 
regulation in comparison to wildtype controls, which may be an indicator for the onset of 
T2DM, while glis3+/sa1645 fish showed no change in resting blood glucose levels 
(p=0.354).  
glis3 Heterozygotes Express Increased Levels of Islet Hormones   
 RNA expression levels where measured in the pancreas and brain of wildtype and 
glis3+/sa17645 heterozygotes under differing dietary constraints (Fig. 12). Total RNA was 
collected using TRIzol RNA extraction. Equal amounts of RNA were used to generate 
cDNA using a high capacity cDNA kit (Applied Biosystems). cDNA was then analyzed 
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by quantitative real time PCR. In both fasting and postprandial conditions, heterozygotes 
expressed increased levels of the primary islet hormone insulin (p<0.005 and p=0.033, 
respectively). Under postprandial condition, heterozygotes also displayed increased 
expression of glucagon (p=0.024).  
 
Figure 12. Islet hormone expression levels under 
dietary restriction. A. Expression of glis3 and insa 
in zebrafish lines while fasting. Pancreatic insulin 
in heterozygotes was significantly increased when 
compared to wildtype fish (p<0.005). Expression 
was normalized with eIF1A levels. B. Expression 
of insa and gcga in zebrafish lines under 
postprandial conditions. Heterozygotes display 
increased levels of both primary islet hormones 
(p=0.033 and p=0.024, respectively). Expression 
was normalized with GapDH levels. C. Expression 
of glis3 in zebrafish lines under postprandial 
conditions. There is no significant difference in the 
expression of glis3 mRNA levels, indicating that 
the heterozygotes may have increased β cell mass 
when compared to wildtypes. Further exploration 
into heterozygote primary islet mass is needed to 
determine if this is the case. Expression was 
normalized using GapDH expression levels.  
 
Zebrafish Display Increased Islet Hormones in Response to HFD 
 Wildtype and glis3+/sa17645 heterozygote fish were submerged in 0.1 M glucose 
and fed 0.1 g of powdered chicken egg yolk three times a week for four months in 
addition to their normal diet to simulate a high fat, high glucose diet. Blood glucose was 
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measured using the FreeStyle Lite Blood Glucose and Monitoring System (Fig. 11), and 
TRIzol RNA extraction was used along side RT-PCR to determine RNA expression 
levels in fish in response to the high fate diet (Fig. 13). Wildtype fish exposed to a high 
fat diet showed no change in RNA expression of glis3 or gcga when compared to 
wildtypes under normal dietary conditions. Heterozygotes exposed to high fat diet 
displayed increased levels of insa (p=0.007) and gcga (p=0.019) when compared to 
wildtype controls (Fig. 13). Heterozygotes show the expected reduced expression of glis3 
in the brain (p=0.013), but do not express reduced glis3 levels in the pancreas. The 
wildtype fish exposed to the high fat diet exhibit extremely reduced glis3 expression in 








Figure 13. RNA expression levels in 
response to a high fat diet. A. Expression 
levels of insa and gcga in zebrafish. WT 
fish under normal dietary conditions 
where used as a control. glis3+/sa17645 fish 
exhibit increased insa (p=0.007) and 
gcga (p=0.019) expression. All RNA 
expression was normalized using 
GapDH. B. Expression of glis3 was 
measured in fish in response to nutrient 
excess. Heterozygotes show the expected 
reduced glis3 levels in the pancreas 
(p=0.014), but not in the pancreas 
(p=0.064). All RNA levels were 

















Discussion and Future Direction 
These studies have shown that glis3 expression levels in zebrafish have a 
significant impact on the expression levels of primary islet hormones. Zebrafish with 
decreased levels of glis3 exhibit increased production of insa and gcga mRNA, and 
glis3+/sa17645 zebrafish exhibit an increased ability to regulate blood glucose. This is 
consistent with previous results that show that overexpression of glis3 in β cells causes a 
reduction in insulin levels, but directly in contrast to the idea that Glis3 is responsible for 
promoting insulin transcription in mice and humans (Kim et al. 2003, Senee et al. 2006, 
Kang et al. 2009, Yang et al. 2009, Yang et al. 2013b). These data indicate that glis3 
might be acting as a repressor of insulin transcription in zebrafish, despite glis3 acting as 
a potent activator of insulin transcription in vitro (Kang et al. 2009, Watanabe et al. 2009, 
Yang et al. 2009, Yang et al. 2013b).  
The increased expression of primary islet hormones in glis3 heterozygous 
zebrafish is indicative of glis3 repression of insa and gcga, which agrees with reporter 
studies indicating glis3 may act to inhibit insulin transcription. This may be due to glis3 
playing a role in the prevention of differentiation into α and β cells, thus loss of glis3 
might result in islet hyperplasia. This idea needs to be examined through 
immunohistochemical staining of islets in HFD challenged heterozygotes. Using whole 
mount in situ hybridization it can be shown that glis3 expression does not begin in the 
pancreatic region until approximately 48 hpf, which is 24 hours after pancreas 
development begins in zebrafish. Zebrafish glis3 expression begins after 14.5 hpf (Fig. 
8), but early expression is restricted to the brain. The late expression of gli3 in the 
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pancreas, coupled with the changes in islet hormone levels in adulthood, may indicate 
that glis3 is required for stopping the signal that induces islet cell formation, or for 
controlling islet cell proliferation during β cell mass expansion.  
Despite the fact that Glis3 has been identifies as a risk locus for the development 
of T1DM and T2DM in humans (Barrett et al. 2009, Boesgaard et al. 2010, Dupuis et al. 
2010) Initial studies of the phenotype of glis3+/sa17645 and glis3sa17645/sa17645 fish indicate 
that loss of glis3 is having no negative impact on physiological health. This is similar to 
Medaka glis3 alternative splice isoform models, which displayed none of the symptoms 
of a pancreatic phenotype (Hashimoto et al. 2009). Glis3 heterozygous and knockout fish 
have exhibited normal feeding and breeding patterns, and no difference in BMI has been 
detected. The only appreciable difference in heterozygote and wildtype fish is the gender 
ratio of their offspring. In the initial steps of producing a complete glis3 knockout line, it 
has become apparent that reduction or loss of glis3 may increase the likelihood of male 
progeny. Further exploration of the gender of the glis3+/sa17656 x glis3+/sa17656 line is needed 
to determine if this biologically significant, or if this discrepancy is due to a low sample 
size. The mechanisms for zebrafish sex determination are currently unknown (von 
Hofsten and Olsson 2005), so an increased propensity towards male offspring in glis3 
mutants would be a novel discovery toward understanding these mechanisms.   
Furthermore, although the sample size is too small to be conclusive, glis3+/sa1645 
zebrafish seem to exhibit tighter regulation of blood glucose homeostasis than compared 
to wildtype fish (Fig. 11). In response to a high fat diet pancreatic glis3, insulin, and gcga 
expression levels in glis3+/sa17645 zebrafish increase compared to wildtypes, while blood 
glucose levels remain normal. The resting blood glucose of wildtype zebrafish exposed to 
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a high fat diet increases, while insulin expression levels remain constant. Since the 
wildtype zebrafish are exhibiting the early symptoms of T2DM while the heterozygous 
remain healthy, we again posit that the reduction in glis3 may be aiding in the 
maintenance of healthy primary islets. Preliminary data indicates that glis3 heterozygotes 
may be more likely to begin the routine mechanism for compensatory β cell mass 
expansion or exhibit an increased production of insulin in existing cells. However, since 
glis3 is not expressed in the α cells of the pancreas, increased gcga production suggests 
an increase in islet mass. The lack of a significant change in glis3 expression levels in the 
pancreas of heterozygous and wildtype zebrafish lines may also be indicative of an 
increase in primary islet mass, as an increase in the number of β cells would lead to 
increased glis3 expression. 
For a more in depth look at the role that glis3 plays in pancreatic function and 
maintenance, the generation of the complete glis3sa17645/sa17645 knockout model will be 
continued. Analysis of glis3, insa, and gcga levels will be repeated for the glis3 knockout 
model under fasting and postprandial condition to determine if the loss of glis3 continues 
the trend of increased pancreatic hormone levels with decreased glis3 levels. Knockout 
glis3 mutants will be exposed to the high fat, high glucose diet and blood glucose and 
pancreatic hormone levels will be monitored to determine if loss of glis3 makes zebrafish 
more likely to develop T2DM.  
Collectively, these studies have indicated that zebrafish glis3 may act as a 
repressor of insulin transcription. The increased likelihood of glis3+/sa17645 to undergo a 
compensatory mechanism for β cell mass expansion in response to nutrient excess may 
lead to the development of models for the study of T2DM. Investigation of pancreas 
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morphology and hormone expression in response to loss of glis3 in environments of 
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Embryo Media 0.5x E2  
      For 1.0 L 
100x E2A     5 ml 
500x E2B     1 ml 
500x E2C     1 ml 
0.1% w/v Methylene Blue   500 ul  
Add reverse osmosis (RO) water to 900 ml. Adjust pH to 7.0-7.2 with concentrated HCl 
or NaOH. Add RO water to 1 L. Store at RT.  
 
100x E2A 
      For 160 ml 
NaCl      14 g 
KCl      0.6 g 
MgSO4     1.92 g 
KH2PO4     0.33 g 
Na2HPO4     0.11 g 
Add Millipore water to a final volume of 160 ml. Stir to dissolve reagents. Sterilize by 






      For 200 ml 
CaCl2      11 g 
Add Millipore water to a final volume of 200 ml. Stir to dissolve reagents. Sterilize by 
autoclaving. Aliquot in 20 ml portions. Store at -20o C. 
 
500x E2C 
      For 200 ml 
NaHCO3     6 g 
Add Millipore water to a final volume of 200 ml. Stir to dissolve reagents. Sterilize by 
autoclaving. Aliquot in 20 ml portions. Store at -20o C. 
 
Luria Bertani (LB) Media 
      For 500 ml 
Tryptone     5 g 
Yeast Extract     2.5 g 
NaCl      5 g 
Agar (if for plates)    7.5 g 
Mix ingredients in 300 ml of water by stirring. Sterilize by autoclaving. Cool to ~55o C 







      For 100 ml 
Tryptone     2 g 
Yeast extract     0.5 g 
NaCl      200 ul (5 M) 
KCl      250 ul (1 M) 
MgCl2      1 ml (1 M) 
MgSO4     1 ml (1 M) 
D-Glucose     2 ml (1 M) 
Dissolve first 4 ingredients in 96 ml ddH2O. Sterilize by autoclaving. Allow to cool to 
RT. Add last 3 ingredients by syringe filtration. Store at 4o C. 
 
8% Paraformaldehyde  
      For 100 ml 
Paraformaldehyde    8 g 
NaOH      600 ul (10 M) 
Mix ingredients in 90 ml of water and stir until paraformaldehyde goes into solution 
without heating. After obtaining a clear solution, add 1 ml 6M HCl and adjust pH to 7.0. 
To prepare a working solution of 4% PFA, combine 50 ml 8% PFA, 10 ml of 10x PBS, 






10x Phosphate Buffered Saline (PBS) 
      For 500 ml 
NaCl      40 g 
KCl      1 g 
Na2HPO4     7.2 g 
KH2PO4     1.2 g 
Disolve reagents in 4oo ml of ddH2O. Adjust pH to 7.4 with HCl. q.s. to 500 ml with 
ddH2O. Sterilize by autoclaving. Store at RT.  
 
Trypsin Solution (0.05%) 
      For 10 ml 
Trypsin      0.05 g 
CaCl2      0.1 g 
Dissolve 0.05 g of trypsin in 10 ml of distilled water. Dissolve 0.1 g of CaCl2 in a 
separate container of 10 ml of distilled water. Add 1 ml of the trypsin solution and 1 ml 
of the CaCl2 solution to 8 ml of distilled water. Adjsut pH to 7.8 with 1 M NaOH and 
store at 4o C. 
 
10x Tris Buffered Saline (TBS) 
      For 500 ml 
Tris      12.1 g 
NaCl      48.8 g 
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Dissolve salts in 400 ml of ddH2O. Adjust pH to 7.6 with HCl. q.s. to 500 ml with 
ddH2O. Sterilize by autoclaving. Store at RT. 
 
Protocols: 
HotSHOT DNA Extraction 
1. Immerse tissue in 100 ul of 50 mM NaOH in a 1.5 ml microcentrifuge tube.   
a. Poke a hole in the lid of the microcentrifuge tube. 
2. Heat for 20 minutes at 95o C. 
a. Shake tube after heating to dissociate tissue. 
3. Chill tubes to 4o C on ice, then add 10 ul of 1 M Tris HCl pH 8.0. 
4. Centrifuge for 10 minutes at 4o C at max speed.  
a. DNA is in the supernatant after centrifuging.  
5. Determine DNA concentration using a nanodrop.  
TOPO TA Cloning 
1. Equilibrate a water bath to 42o C. 
2. Warm SOC broth and AMP+ LB culture plates to 37o C in an incubator.  
3. Set up the TOPO cloning reaction: 
a. 2 ul of PCR product DNA 
b. 1 ul TOPO salt solution 
c. 1 ul TOPO vector 
d. 2 ul RNAse free water 
4. Incubate at RT for 5 minutes 
5. Add 2 ul of the TOPO cloning reaction to 50 ul of DH5α cells, mix gently.  
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6. Incubate on ice for 5 minutes.  
7. Heat shock in the 42o C water bath for 30 seconds without shaking. 
8. Place on ice, and add 250 ul of prewarmed SOC. 
9. Shake tubes horizontally for 1 hour at 37o C. 
10. Add 50 ul of the transformation to the prewarmed Amp+ LB plate and incubate 
overnight at 37o C. 
11. Choose 3 to 4 colonies and incubate each in 3 ml of AMP+ LB broth at 37o C 
while rocking horizontally.  
12. Purify amplified DNA using a plasmid miniprep kit. 
Site Directed Mutagenesis 
1. Dilute plasmid DNA (from TOPO TA cloning) to 50 ng/ul.  
2. Set up PCR reaction: 
a. 5 ul of 10x PFU buffer. 
b. 1.25 ul of 100 ng/ul forward primer. 
c. 1.25 ul of 100 ng/ul reverse primer. 
d. 1 ul of dNTP mix. 
e. 1 ul of 50 ng/ul plasmid DNA 
f. RNAse free water to a final volume of 50 ul. 
3. Add 1 ul of PFU Turbo DNA polymerase 
4. Run PCR cycle: 
a. 1 cycle 
i. 95o C for 30 seconds. 
b. 12 cycles 
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i. 95o C for 30 seconds. 
ii. 55o C for 1 minute. 
iii. 68o C for 5 minutes. 
c. 1 cycle 
i. 68o C for 10 minutes. 
5. Add 1 ul of Dpn I restriction enzyme. 
6. Gently mix the reaction, then spin down for one minute.  
7. Incubate at 37o C for 1 hour. 
8. Add 45 ul of XL10-Gold competent cells and 2 ul of β-mercaptoethanol to a 
separate, prechilled microcentrifuge tube.  
a. Incubate on ice for 10 minutes, swirling every 2 minutes.  
9. Add 2 ul of Dpn I treated DNA to the tube and incubate on ice for 30 minutes.  
10. Transfect mutated DNA into the XL10-Gold competent cells (Steps 7-12 from 
TOPO TA Cloning protocol). 
TaqMan SNP Genotyping Assay 
1. Create a master mix using, for each sample: 
a. 12.5 ul of 2x TaqMan Universal PCR Master Mix. 
b. 1.25 ul of 20x SNP Genotyping Assay 
c. 9.25 ul of RNAse free water. 
2. Load the master mix into an RT-PCR well plate. Each sample gets 23 ul of the 
master mix and 2 ul 25 ng/ul DNA. 
3. Run the PCR cycle 
a. 1 cycle 
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i. 95o C for 10 minutes. 
b. 40 cycles 
i. 92o C for 15 seconds. 
ii. 60o C for 1 minute. 
TRIzol RNA Extraction 
1. Place ~30 eggs (or organ tissue) in a 1.5 ml sterile microcentrifuge tube.  
2. Add 250 ul of TRIzol and lyse cells with a pestle. 
3. Add 750 ul of TRIzol and incubate at RT for 5 minutes.  
4. Add 200 ul of phenol:chloroform and gently invert for 15 seconds.  
5. Incubate at RT for 2 minutes, then centrifuge at 12,000 x g for 15 minutes at 4o C. 
6. Transfer the clear aqueous top layer to a new tube and add 500 ul of isopropanol.  
7. Incubate at RT for 10 minutes.  
8. Spin for 10 minutes at 12,000 x g and 4o C. Remove supernatant and wash in 1 ml 
of 75% ethanol.  
9. Centrifuge for 5 minutes at 7,500 x g and 4o C. Remove ethanol and allow pellet 
to air dry for 10 minutes while inverted. 
10. Resuspend RNA in 100 ul of RNAse free water, store at -80o C.  
